1 |
Arbyn M, Andersson K, Bergeron C, et al (2011). Cervical cytology biobanks as a resource for molecular epidemiology. Methods Mol Biol, 675, 279-98.
DOI
ScienceOn
|
2 |
Bartel DP (2009). MicroRNAs, target recognition and regulatory functions. Cell, 136, 215-33.
DOI
ScienceOn
|
3 |
Chang CK, Hung WC, Chang HC (2008). The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med, 12, 12-6.
|
4 |
Cong N, Du P, Zhang A, et al (2013). Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/ -catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep, 10, 3892-7.
|
5 |
Curran S, Murray GI (2000). Matrix metalloproteinases, molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer, 36, 1621-30
DOI
ScienceOn
|
6 |
Dai Y, Xia W, Song T, et al (2013). MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells. Nucleic Acid Ther, 23, 29-34.
|
7 |
Denny Lynette (2012). Cervical cancer, prevention and treatment. Discov Med, 14, 125-11.
|
8 |
Eissa S, Ali-Labib R, Swellam M, et al (2007). Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol, 52, 1388-96.
DOI
ScienceOn
|
9 |
Fang L, Deng Z, Shatseva T, et al (2011). MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin- . Oncogene, 30, 806-21.
DOI
ScienceOn
|
10 |
Figueira RC, Gomes LR, Neto JS, et al (2009). Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer, 9, 20-5.
DOI
ScienceOn
|
11 |
Liu S, Patel SH, Ginestier C, et al (2012). MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet, 8, e1002751.
DOI
|
12 |
Kim VN, Han J, Siomi MC (2009). Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol, 10, 126-39.
DOI
ScienceOn
|
13 |
Kodate M, Kasai T, Hashimoto H, et al (1997). Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int, 47, 461-9.
DOI
ScienceOn
|
14 |
Lee JH, Welch DR (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res, 57, 2384-7.
|
15 |
Liabakk NB, Talbot I, Smith RA, et al (1996). Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenase in colorectal cancer. Cancer Res, 56, 190-6.
|
16 |
Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.
DOI
ScienceOn
|
17 |
Long NK, Kato K, Yamashita T, et al (2008). Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncol, 44, 1052-8.
DOI
ScienceOn
|
18 |
Ma D, Zhang YY, Guo YL, Li ZJ, Geng L (2012). Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer. Chin Med J, 125, 4270-76.
|
19 |
Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
DOI
ScienceOn
|
20 |
Lui WO, Pourmand N, Patterson BK, Fire A (2007). Patterns of known and novel small RNAs in human cervical cancer. Cancer Res, 67, 6031-43.
DOI
ScienceOn
|
21 |
Mori T, Moriuchi R, Okazaki E, et al (2007). Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region. Biochem Biophys Res Commun, 355, 937-43.
DOI
ScienceOn
|
22 |
Namwat N, Puetkasichonpasutha J, Loilome W, et al (2011). Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. J Gastroenterol, 46, 664-75.
DOI
|
23 |
Oh J, Takahashi R, Kondo S, et al (2001). The membrane anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell, 107, 789-800.
DOI
ScienceOn
|
24 |
Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA (2010). MicroRNA expression variability in human cervical tissues. PLoS One, 5, e11780.
DOI
ScienceOn
|
25 |
Perry SV (2001). Vertebrate tropomyosin, distribution, properties and function. J Muscle Res Cell Motil, 22, 5-49.
DOI
ScienceOn
|
26 |
Rasheed SA, Teo CR, Beillard EJ, Voorhoeve M, Casey PJ (2013). MicroRNA-182 and microRNA-200a control G-protein subunit alpha-13 (GNA13) expression and cell invasion synergistically in prostate cancer. Cells J Biol Chem, 10, 1074-7.
|
27 |
Rodriguez-Paredes M, Esteller M (2011). Cancer epigenetics reaches mainstream oncology. Nat Med, 17, 330-9.
|
28 |
Takagi S, Simizu S, Osada H (2009). RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res, 69, 1502-8.
DOI
ScienceOn
|
29 |
Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, et al (2008). MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol, 26, 462-9.
DOI
ScienceOn
|
30 |
Reis ST, Leite KR, Piovesan LF, et al (2012). Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urol, 12, 18-23.
DOI
ScienceOn
|
31 |
Miki T, Shamma A, Kitajima S, et al (2010). TThe -integrindependent function of RECK in physiologic and tumor angiogenesis. Mol Cancer Res, 8, 665-76.
DOI
|
32 |
TChung TT, Yeh CB, Li YC, et al (2012). Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features. Plos one, 7, e33517.
DOI
|
33 |
Toi M, Ishigaki S, Tominaga T(1998). Metalloproteinases and tissue inhibitors of metallo-proteinases. Breast Cancer Res Treat, 52, 113-24.
DOI
ScienceOn
|
34 |
Wang X, Tang S, Le SY, et al(2008). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557.
DOI
ScienceOn
|
35 |
Welch DR, Steeg PS, Rinker-Schaeffer CW (2000). Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res, 2, 408-16.
DOI
ScienceOn
|
36 |
Wu L, Belasco JG (2008). Let me count the ways, mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell, 29, 1-7.
DOI
ScienceOn
|
37 |
Yang J, Mani SA, Donaher JL, et al (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-39.
DOI
ScienceOn
|
38 |
Yang L, Parkin DM, Li L, Chen Y (2003). Time trends in cancer mortality in China, 1987-1999. Int J Cancer, 106, 771-83.
DOI
ScienceOn
|
39 |
Yu SJ, Hu JY, Kuang XY, et al (2013). MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer. Clin Cancer Res, 10, 1158-63.
|
40 |
Yu XF, Zou J, Bao ZJ, Dong J (2011). miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol, 17, 4711-7.
DOI
ScienceOn
|
41 |
Zhang B, Zhang J, Xu ZY, Xie HL (2009). Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. BMC Cancer, 9, 427-35.
DOI
ScienceOn
|
42 |
Zhang C, Ling Y, Zhang C, et al (2012). The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma. Int J Biol Sci, 8, 451-8.
DOI
|